MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation DPO Ratio 2011-2026 | BRKR
Annual DPO Ratio Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.4 | 47.9 | 48.5 | 42.6 | 46.9 | 40.1 | 38.3 | 34.8 | 36.2 | 28.8 | 26.5 | 26.4 | 26.5 | 29.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 48.5 | 26.4 | 37.1 |
Quarterly DPO Ratio Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.7 | 53.2 | - | 45.9 | - | - | - | 46.9 | 51.5 | 52.5 | - | 23.7 | 25.3 | 48.8 | - | 43.1 | 46.4 | 47.4 | - | 46.7 | 51.5 | 49.8 | - | 40.4 | 41.6 | 41.2 | - | 39.1 | 40 | 38.4 | - | 35 | 36 | 38.7 | - | 37.6 | 39 | 34.6 | - | 28.8 | 29 | 35 | - | 27.5 | 27 | 28.2 | - | 27.8 | 26.9 | 30.1 | - | 26.7 | 27.3 | 30.1 | - | 28.8 | 30.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 53.2 | 23.7 | 37.5 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K |  USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.22 | - | $ 121 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Globus Medical
GMED
|
33.1 | $ 93.7 | 0.07 % | $ 12.7 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 13.08 | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.28 | - | $ 52.1 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 12.32 | - | $ 488 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | - | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 11.21 | - | $ 317 M | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.35 | - | $ 6.52 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 26.0 | - | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 329.01 | -0.03 % | $ 126 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 24.24 | -3.31 % | $ 554 M | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.8 | - | $ 37.6 M | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 108.12 | - | $ 3.68 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.12 | - | $ 1.29 M | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 19.82 | - | $ 1.35 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
51.3 | $ 5.48 | -0.09 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Varex Imaging Corporation
VREX
|
42.5 | $ 12.71 | - | $ 526 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.82 | - | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.84 | - | $ 388 M | USA |
 |
Beyond Air
XAIR
|
133 | $ 0.49 | - | $ 33.2 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 63.41 | - | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.08 | - | $ 18.3 M | USA |
 |
Xtant Medical Holdings
XTNT
|
43.2 | $ 0.53 | - | $ 74 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
50.4 | $ 92.59 | - | $ 18.8 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.87 | - | $ 1.18 B | USA |